Shariq Haider, MD, FRCPC, FACP, CCST

Juravinski Hospital and Cancer Center, Canada

Disclosure(s): Merck: Advisor/Consultant; Takeda: Advisor/Consultant, Clinical Trials

Poster(s):

• (P-2131) Impact of Cytomegalovirus Clearance on Outcomes in Hematopoietic Cell Transplant Recipients with Refractory, Resistance or Intolerance to Treatments: Retrospective Study in Europe, Canada and Israel
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET